Abstract-Blood-brain barrier (BBB) dysfunctions have been implicated in the progression of Alzheimer's disease. Cerebral endothelial cells (CECs) and astrocytes are the main cell components of the BBB. Although amyloid-␤ oligomers (A␤ 42 ) have been reported to mediate oxidative damage to the CECs and astrocytes and trigger the downstream mitogenactivated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) pathway, the cell surface binding site for A␤ 42 and exact sequence of these events have yet to be elucidated. In this study, the receptor for advanced glycation endproducts (RAGE) was postulated to function as a signal transducing cell surface receptor for A␤ 42 to induce reactive oxygen species (ROS) generation from NADPH oxidase and trigger downstream pathways for the phosphorylation of extracellular signal-regulated kinases (ERK1/2) and cytosolic phospholipase A 2 (cPLA 2 ). We found that A␤ 42 competed with the anti-RAGE antibody (Ab RAGE ) to bind to RAGE on the surfaces of CECs and primary astrocytes. In addition, Ab RAGE abrogate A␤ 42 -induced ROS production and the colocalization between the cytosolic (p47-phox) and membrane (gp91-phox) subunits of NADPH oxidase in both cell types. Ab RAGE as well as NADPH oxidase inhibitor and ROS scavenger suppressed A␤ 42 -induced ERK1/2 and cPLA 2 phosphorylation in CECs. At the same time, only Ab RAGE , but neither NADPH oxidase inhibitor nor ROS scavenger, inhibited the ERK1/2 pathway and cPLA 2 phosphorylation in primary astrocytes. Therefore, this study demonstrates that NADPH oxidase complex assembly and ROS production are not required for A␤ 42 Alzheimer's disease (AD) is a chronic neurodegenerative disorder, which affects approximately 10% of the population at age 65 and older. The pathology of AD is characterized by an increased deposition of amyloid-␤ peptide (A␤) in the brain and a progressive impairment of cognition and memory of affected individuals. Blood-brain barrier (BBB) dysfunction is observed in all of the stages of AD and may even precede neuron degeneration in AD brains (Hofman et al., 1997; Iadecola, 2003; Ruitenberg et al., 2005; de la Torre, 2006; Girouard and Iadecola, 2006; Deane and Zlokovic, 2007; Zlokovic, 2008; Bell and Zlokovic, 2009 ). During the early stages of AD, microvasculature deficiencies and hypertrophy of astrocytes are commonly observed (Farkas and Luiten, 2001; Borroni et al., 2002) . Numerous in vivo and in vitro studies have demonstrated that the vascular deposition of A␤ induces oxidative stress in cerebral vasculature and astrocytes (Cai et al., 2003; Abramov and Duchen, 2005) . A␤-induced oxidative stress in cells, in turn, initiates a cascade of redox reactions leading to apoptosis and neurovascular inflammation (Blanc et al., 1997; Suo et al., 1998; Tan et al., 1999; Yin et al., 2002; Hsu et al., 2007; Vukic et al., 2009) .
Alzheimer's disease (AD) is a chronic neurodegenerative disorder, which affects approximately 10% of the population at age 65 and older. The pathology of AD is characterized by an increased deposition of amyloid-␤ peptide (A␤) in the brain and a progressive impairment of cognition and memory of affected individuals. Blood-brain barrier (BBB) dysfunction is observed in all of the stages of AD and may even precede neuron degeneration in AD brains (Hofman et al., 1997; Iadecola, 2003; Ruitenberg et al., 2005; de la Torre, 2006; Girouard and Iadecola, 2006; Deane and Zlokovic, 2007; Zlokovic, 2008; Bell and Zlokovic, 2009 ). During the early stages of AD, microvasculature deficiencies and hypertrophy of astrocytes are commonly observed (Farkas and Luiten, 2001; Borroni et al., 2002) . Numerous in vivo and in vitro studies have demonstrated that the vascular deposition of A␤ induces oxidative stress in cerebral vasculature and astrocytes (Cai et al., 2003; Abramov and Duchen, 2005) . A␤-induced oxidative stress in cells, in turn, initiates a cascade of redox reactions leading to apoptosis and neurovascular inflammation (Blanc et al., 1997; Suo et al., 1998; Tan et al., 1999; Yin et al., 2002; Hsu et al., 2007; Vukic et al., 2009) .
A␤-induced oxidative stress is associated with overproduction of reactive oxygen species (ROS) (Park et al., 2005 (Park et al., , 2008 Girouard and Iadecola, 2006; Callaghan et al., 2008) . ROS can be generated by several enzymatic systems, but there is evidence that the superoxide-producing enzyme, NADPH oxidase, is a major source of ROS in cerebral endothelial cells (CECs) and astrocytes (Cai et al., 2003; Abramov and Duchen, 2005; Park et al., 2005 Park et al., , 2008 Liu et al., 2005; Zhu et al., 2009) . Although these studies demonstrate that A␤ mediates oxidative damage to astrocytes and CECs mainly through the activation of NA-DPH oxidase, how A␤ activates NADPH oxidase has yet to be elucidated.
A␤-induced cytotoxic effects are also associated with the activation of MAPK/ERK1/2 cascade and the phosphorylation of cytosolic phospholipase A 2 (cPLA 2 ) (Stephenson et al., 1996; McDonald et al., 1998; Dineley et al., 2001; Moses et al., 2006; Zhu et al., 2006; Shelat et al., 2008; Young et al., 2009 ). The ERKs (extracellular signalregulated kinases) are widely expressed protein kinases and part of a signal transduction system through which extracellular stimuli are transduced. Activation of ERKs occurs in response to growth factor stimulation, cytokines, virus infection, transforming agents, carcinogens, and after the activation of high-affinity IgG receptors (McDonald et al., 1998) . Phospholipases A 2 (PLA 2 s) are ubiquitously distributed enzymes that catalyze the hydrolysis at the sn-2 position of phospholipids to produce lysophospholipids and release arachidonic acid (Murakami and Kudo, 2002; Sun et al., 2004 ). PLA 2 s are classified into three major families: calcium-dependent cytosolic PLA 2 (cPLA 2 ), secretory PLA 2 (sPLA 2 ), and calcium-independent PLA 2 (iPLA 2 ). cPLA 2 has been implicated in diverse cellular responses, such as mitogenesis, differentiation, inflammation, and cytotoxicity, and overproduction of this enzyme is involved in many neurodegenerative diseases, including AD (Stephenson et al., 1996; Sun et al., 2007) .
Recent studies have indicated that the receptor for advanced glycation endproducts (RAGE) is a binding site for A␤ (Yan et al., 1996; Lue et al., 2001; Sasaki et al., 2001; Arancio et al., 2004; Chaney et al., 2005) . RAGE is a multiligand cell surface receptor, which is normally expressed in brain endothelium and, at low levels, in microglia and neurons (Lue et al., 2001; Sasaki et al., 2001; Zlokovic, 2008) . However, in AD brains, RAGE expression is increased by several folds in CECs, astrocytes, microglia, and neurons (Lue et al., 2001; Sasaki et al., 2001) . A␤ binding to RAGE has been demonstrated to regulate A␤ transport across BBB, upregulate proinflammatory cytokines and adhesion molecules in CECs, and contribute to the transport of A␤ from the cell surface into the intracellular space in cortical neurons (Giri et al., 2000; Lue et al., 2001; Takuma et al., 2009) . Since RAGE has been postulated to function as a signal-transducing cell surface receptor for A␤, it is reasonable to hypothesize that binding of A␤ 1-42 oligomers (A␤ 42 ) to surface RAGE results in activation of NADPH oxidase to induce ROS generation, and activate downstream pathways, including phosphorylation of ERK1/2 and cPLA 2 .
EXPERIMENTAL PROCEDURES Cell cultures and treatment
Mouse bEND3 line of CECs was purchased from Fisher Scientific (Pittsburgh, PA, USA). Rat primary cortical astrocytes were purchased from Invitrogen (Carlsbad, CA, USA). Purity of astrocyte culture was verified by double immunostaining with astrocytic marker (primary mouse monoclonal antibody to S100, Abcam Inc., Cambridge, MA, USA) and microglia marker (primary rabbit polyclonal to antibody coronin 1a, Neuromics, Edina, MN, USA). The purity of astrocytes obtained from Invitrogen is 100%.
A␤ 42 and scrambled sequence peptide (A␤ 42-1 ) from American Peptide (Sunnyvale, CA, USA) were prepared by diluting 5 mM A␤ in DMSO to 100 M in ice-cold culture Ham's medium, and sonicated. The oligomeric form of A␤ 42 in cell culture was verified by Western blot analysis. Menadione (Sigma, St. Louis, MO, USA) was dissolved in DMSO (1 mg/ml) and then diluted in cell culture medium to final concentration of 50 M; rabbit polyclonal antibody against RAGE (Ab RAGE , Abcam Inc.), the specific NADPH oxidase inhibitor, gp91ds-tat (AnaSpec, Fremont, CA, USA), and ROS scavenger, tiron (Sigma), were diluted in DMEM. Experimental groups: control (cells without any treatment); cells treated with 2 and 5 M of A␤ 42 for 1 and 2 h; cells treated with Ab RAGE for 4 h; cells treated with Ab RAGE followed by A␤ 42 (5 M for 2 h) treatment; cells treated with gp91ds-tat (1 M for 1 h) and tiron (5 mM for 1 h) followed by treatment with A␤ 42 . Cells treated with menadione (50 M for 30 min) and A␤ 42-1 (5 M for 2 h) served as a positive and negative controls.
Immunofluorescent staining for RAGE
Cells were grown on cover slips until confluence. After treatment with A␤ 42 (2 and 5 M for 1 h), cells were fixed immediately using 3.7% paraformaldehyde solution for 30 min. To block non-specific binding, 5% sheep serum in PBS was applied to the cells for 1 h. RAGE at the cell surface was labeled with its primary antibody (Abcam) without permeabilization at 4°C overnight, followed by sheep secondary antibody (Abcam) labeling at 25°C for 1 h. To confirm the specificity of the primary antibodies, cells were labeled by secondary antibodies alone. Secondary antibodies did not show immunostaining in the absence of the primary antibody.
Measurement of ROS production
DHE (dihydroethidium) staining was applied to determine superoxide anion production (Zanetti et al., 2005) . DHE reacts with O 2
•Ϫ to produce oxyethidium (oxy-E), a highly fluorescent product, which binds to DNA and causes an increased fluorescent intensity in cell nuclei. For ROS measurements, cells were starved for 4 h, rinsed twice with warm phenol free DMEM, and incubated with DHE (20 M) for 2 h.
Quantitative immunofluorescence microscopy (QIM)
Bright-field illumination and fluorescence microscopy were performed with Nikon TE-2000 U fluorescence microscope and 40ϫ, NA 0.95 objective. Images were acquired using a cooled CCD camera controlled with a computer and uses MetaView imaging software. The typical exposure time for fluorescence image acquisition was 400 ms. Background was subtracted for all images before analysis. Relative expression of RAGE was quantified by calculating the intensity of secondary antibody fluorescence per cell. The intensity was then normalized by the control cells (without any treatment). A similar approach was applied to quantify the oxy-E fluorescence.
Double immunofluorescent labeling of gp91-phox and p47-phox
Cells were grown on cover slips until confluence. After treatment, cells were fixed immediately using 3.7% paraformaldehyde solution for 30 min. To block non-specific binding, 5% mixture of sheep and donkey serum in PBS was applied to the cells for 1 h. Plasma membrane gp91-phox was labeled with its primary antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) without permeabilization at 4°C overnight. For p47-phox labeling, cells were permeabilzed by 0.1% Triton X-100 in PBS for 5 min and labeled with its primary antibody (Santa Cruz Biotechnology) at 4°C overnight, followed by sheep and donkey polyclonal secondary antibodies (Abcam) labeling at room temperature for 1 h. The emission spectra of the secondary antibodies were 528 nm (for gp91-phox) and 620 nm (for p47-phox). To confirm the specificity of the primary antibodies, cells were labeled by secondary antibodies alone. Secondary antibodies did not show immunostaining in the absence of the primary antibody.
Confocal immunofluorescence microscopy
Confocal immunofluorescence microscopy was performed with Olympus FV1000 confocal microscope. Confocal images were acquired with a 60ϫ, numerical aperture 1.2 oil immersion objective lens for colocalization studies of the cellular surface gp91-phox and p47-phox. The colocalization images were obtained by suppressing all colors, except yellow, in superimposed images using Matlab and Adobe Photoshop. A z-series at 1-m intervals was captured to determine the spatial colocalization characteristics of gp91-phox or p47-phox staining within individual cells. The colocalization (the area of coincident intensity) between two channels was quantified by normalizing the coincident intensity (yellow) to the total intensity of the corresponding channel.
Western blot analysis
Following the treatments, primary astrocytes and CECs were harvested in 300 l sample buffer containing 50 mM Tris-HCl, pH 7.4, 1 mM EDTA, 100 mM NaCl, 0.1% sodium dodecyl sulfate, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium O-vanadate, 1 g/mL leupeptin, 1 g/ml pepstatin, and 10 g/ml aprotinin. Lysates were collected, sonicated, and equivalent amounts of each sample (40 l) were resolved in 11.55% Tris-HCl gel electrophoresis. After electrophoresis, proteins were transferred to nitrocellulose membranes. Membranes were incubated in Tris-buffered saline, pH 7.4, with 0.5% Tween 20 (TBS-T) containing 5% non-fat milk for 1 h at room temperature. The blots were then washed and reacted with either rabbit anti-phospho-cPLA 2 (1:600; Cell Signaling Technology, Boston, MA, USA) or rabbit anti-cPLA 2 (1:600; Cell Signaling Technology) or mouse anti-phospho-ERK1/2 (1: 4000, Cell Signaling Technology) and rabbit anti-ERK1/2 (1:500; Cell Signaling Technology) overnight at 4°C. After washing with TBS-T, they were incubated with goat anti-rabbit and goat antimouse IgG-horseradish peroxidases (1:5000; Santa Cruz) for 1 h at room temperature. The blots were then washed three times with TBS-T. Immunolabeling was detected by chemiluminescence (SuperSignal West Pico and West Fempto). For quantification, blots were scanned and intensity of protein bands was measured as optical density using the Quantity One program (BioRad, Hercules, CA, USA). Phospho-ERK1/2 and ERK1/2 were detected at 42/44 kDa, and phospho-cPLA 2 and cPLA 2 were detected at 110 kDa. Ratios of phospho-ERK1/2 to ERK1/2 and phospho-cPLA 2 to cPLA 2 were calculated for each sample and normalized to the control.
Statistical analysis
Data from at least three independent experiments are reported as meanϮSD. Mean differences between experimental groups were tested with unpaired t-test. Values were considered significantly different at the PՅ0.05 level. Statistical analyses were performed on the Sigma Plot 8.0 software.
RESULTS

Oligomeric A␤ 42 interacts with the RAGE
It has been reported that the binding of soluble A␤ to soluble RAGE inhibits further aggregation of A␤ peptides, while membrane-bound RAGE-A␤ interactions elicit activation of the NF-B transcription factor and promote sustained chronic neuroinflamation (Chaney et al., 2005) . To further provide evidence that RAGE is the binding site for A 42 , we examined with the immunofluorescence microscopy of RAGE for primary astrocytes and CECs pretreated with 2 and 5 M of oligomeric A␤ 42 at 37°C and 4°C (in which condition the internalization of surface receptors is suppressed). A lower fluorescent intensity of labeled RAGE was observed for cells pretreated with oligomeric A␤ 42 in both temperature conditions (Fig. 1) , suggesting that A␤ 42 oligomers compete with Ab RAGE to bind to RAGE at the surface of the astrocytes as well as CECs.
Polyclonal antibody to RAGE and NADPH inhibitor suppress A␤ 42 -induced ROS production in astrocytes and CECs
To investigate ROS production in cells, we applied fluorescent microscopy of DHE, which reacts with O 2
•Ϫ to produce oxy-E with a higher quantum yield. Fig. 2 shows the images of DHE-stained CECs (A) and astrocytes (B) treated with A␤ 42 oligomers, A␤ 42-1 , Ab RAGE , ROS scavenger (tiron), and NADPH oxidase inhibitor (gp91ds-tat). Quantitative analysis was accomplished by integration of fluorescent intensity for each cell. Fig. 2C, D show that 5 M of A␤ 42 increased DHE fluorescence in both primary astrocytes as well as in CECs by ϳ 75% as compared with the control. Since menadione has been reported previously to induce ROS generation in astrocytes (Zhu et al., 2009) , results from the treatment of menadione served as a positive control ( Fig. 2A) . As a negative control, reversed A␤ 42-1 did not increase ROS generation. At the same time, A␤ 42 -stimulated ROS production in CECs and astrocytes was attenuated by blocking the cell surface RAGE with its antibody ( Fig. 2A, C) , or by the pretreatment with gp91ds-tat, the specific NADPH oxidase inhibitor (Fig. 2B, D) . Ab RAGE, or the inhibitor alone had no effect on DHE intensity. As a control, scrambled sequence peptide sr-gp91ds-tat (srgp) did not suppress A␤ 42 -induced ROS overproduction. To verify this technique of measurement for superoxide anions, we demonstrated that ROS scavenger suppressed an A␤ 42 -mediated increase in DHE intensity. These data suggest that A␤ 42 oligomers induce ROS production through their binding to RAGE leading to NADPH oxidase activation.
Polyclonal antibody to RAGE suppresses A␤ 42 -induced colocalization of cytosolic subunit p47-phox of NADPH oxidase with its membrane subunits gp91-phox Ab RAGE as well as NADPH oxidase inhibitor suppressed A␤ 42 -induced ROS production in CECs and astrocytes (Fig. 2C, D) . NADPH oxidase is a membrane-bound enzyme that catalyzes the production of ROS from oxygen and NADPH. NADPH oxidase is a complex system consisting of two membrane-bound elements (gp91-phox and p22-phox), three cytosolic components (p67-phox, p47-phox, and p40-phox), and a low-molecular-weight G protein (Babior, 1999) . Activation of NADPH oxidase is associated with the migration of the cytosolic components to the cell membrane and assembling with its membrane subunits. To confirm the role of A␤ 42 -RAGE interactions in NADPH oxidase activation and subsequent ROS generation, we quantified the effect of A␤ 42 and Ab RAGE on the colocalization of p47-phox with gp91-phox by analyzing confocal images of double immunofluorescent-labeled gp91-phox and p47-phox in astrocytes and CECs (Fig. 3A,  B) . Our results indicate that A␤ 42 significantly increased the colocalization of cytosolic subunit p47-phox of NADPH oxidase with its membrane subunits gp91-phox, suggesting that A␤ 42 enhances NADPH oxidase complex assembling. At the same time, pretreatment with Ab RAGE signifi-cantly suppressed the colocalization of p47-phox with gp91-phox induced by A␤ 42 . To validate the fluorescent confocal microscopy method for measurement of the colocalization between these two subunits, we demonstrated that NADPH oxidase inhibitor (gp91ds-tat) suppressed A␤ 42 -mediated increase in colocalization (Fig. 3A, B) . The inhibitor alone, as well as Ab RAGE, had no effect on the colocalization. These data indicated that A␤ 42 oligomers induced colocalization of cytosolic subunit p47-phox of NADPH oxidase with its membrane subunits gp91-phox and subsequent ROS generation through binding to RAGE.
Polyclonal antibody to RAGE inhibits A␤ 42 -induced phosphorylation ERK1/2 and cPLA 2 in primary astrocytes and CECs
A␤ 42 has been shown to induce MAPK/ERK downstream signaling pathways, including the activation of ERK, which further leads to phosphorylation of cPLA 2 (Blanc et al., 1997; Xu et al., 2001; Yin et al., 2002; Hsu et al., 2007; Shelat et al., 2008 ). Here, we tested if A␤ 42 binding to RAGE induced ERK1/2 activation and phosphorylation of cPLA 2 in CEC and astrocytes. Fig. 4 shows that A␤ 42 significantly increased phosphorylation of ERK1/2 and cPLA 2 in astrocytes and CECs, which were suppressed by the pretreatment with Ab RAGE . Additionally, Ab RAGE alone had no effect on phosphorylation of ERK1/2 and cPLA 2 in both cell types. Our data suggested that A␤ 42 binding to RAGE is required for the activation of ERK1/2 and further phosphorylation of cPLA 2 induced by A␤ 42 .
Effects of NADPH oxidase inhibitor and ROS scavenger on ERK1/2 and cPLA 2 phosphorylation in CECs and primary astrocytes
ROS from NADPH oxidase has been shown to induce the activation of ERK1/2 and phosphorylation of cPLA 2 in primary neurons (Shelat et al., 2008) . Our data suggest that A␤ 42 oligomers induce ROS production through binding to RAGE, which activates NADPH oxidase, and thus blocking cell surface RAGE with its antibody suppresses A␤-induced phosphorylation of ERK1/2 and cPLA 2 in CECs and primary astrocytes. Therefore, we hypothesized that A␤ 42 binding to RAGE induces phosphorylation of ERK1/2 and cPLA 2 through activation of NADPH oxidase and ROS production.
In support of our hypothesis, Fig. 5B , C, E, F show that pretreatment of CECs with NADPH oxidase inhibitor or ROS scavenger could significantly suppress A␤ 42 -induced phosphorylation of ERK1/2 and cPLA 2 . Surprisingly, only Ab RAGE , but neither NADPH oxidase inhibitor nor ROS scavenger, inhibited A␤ 42 -induced ERK1/2 and cPLA 2 phosphorylation in primary astrocytes (Figs. 4A, B and 5A, C, D, F). NADPH oxidase inhibitor alone, as well as ROS scavenger, had no effect on phosphorylation of ERK1/2 and cPLA 2 in both cell types (Fig. 5A-F) .
These data suggest a presence of two different downstream pathways in the CECs and astrocytes. Although A␤ 42 binding to RAGE is required to induce phosphorylation of ERK1/2 and cPLA 2 in both CECs and primary astrocytes, NADPH oxidase inhibition does not suppress phosphorylation of ERK1/2 and cPLA 2 in primary astrocytes.
DISCUSSION
Results from this study provided support for the involvement of RAGE in A␤ 42 -mediated oxidative stress and downstream MAPK/ERK pathway in CECs and astrocytes. Specifically, we demonstrated that A␤ 42 oligomers directly bind to RAGE at the surface of the cells to induce colocalization between NADPH oxidase subunits gp91-phox and p47-phox, and subsequently leading to generation of ROS, and phosphorylation of ERK1/2 and cPLA 2 in CECs. Interestingly, our data also showed that activation of NADPH oxidase and increased ROS production were not required for A␤-induced phosphorylation of ERK1/2 and cPLA 2 in astrocytes.
In agreement with impairments of BBB structure and functions in AD, many studies have indicated a decrease in cerebral blood flow, reduced microvascular density, and low immunoreactivity of endothelial markers CD34 and CD31 in AD brains (Kalaria and Pax, 1995; Buee et al., 1997; Berzin et al., 2000; Bailey et al., 2004; Ervin et al., 2004 major factor leading to a BBB cell dysfunction in AD, the mechanism for production of A␤-induced ROS has not been clearly elucidated (Smith et al., 1991; Behl et al., 1994; Mecocci et al., 1994; Cini and Moretti, 1995; Simonian and Coyle, 1996; Behl and Holsboer, 1998; Heneka and O'Banion, 2007) . Recently, RAGE has been postulated to function as a signal-transducing cell surface acceptor for A␤ (Yan et al., 1996; Lue et al., 2001; Sasaki et al., 2001; Arancio et al., 2004; Chaney et al., 2005) . In fact, the possible links between RAGE and oxidative stress has been reported (Yan et al., 1996; Lue et al., 2001; Sasaki et al., 2001; Arancio et al., 2004; Chaney et al., 2005) . ROS has been demonstrated to be generated by the advanced glycation end products (AGE)-RAGE interaction in human endothelial cells (Wautier et al., 2001) . Inhibition studies have indicated that anti-RAGE IgG significantly suppressed oxidative stress induced by A␤, both in vascular and neuronal cell (Yan et al., 1996) ; however, the relationship between A␤-RAGE interactions and NADPH oxidase has yet to be elucidated.
It is suggested that NADPH oxidase is the primary source of superoxide in astrocytes and CECs (Cai et al., 2003; Abramov and Duchen, 2005; Park et al., 2005 Park et al., , 2008 Liu et al., 2005; Zhu et al., 2009 ). We have previously reported that A␤ 42 oligomers induce ROS generation through activation of NADPH oxidase in primary astrocytes (Zhu et al., 2006) . It has been shown that inhibition of NADPH oxidase significantly suppressed ROS released in rat astrocytes (Liu et al., 2005) . A␤-induced ROS overproduction and mitochondrial depolarization were absent in astrocytes cultured from gp91phox knockout transgenic mice (Abramov and Duchen, 2005) . In a mouse model of AD, inhibition of NADPH oxidase has been found to abrogate A␤-induced ROS production and alteration of cerebrovascular functions (Park et al., 2005) . APP transgenic mice lacking the NADPH oxidase subunits gp91-phox or phagocytic NADPH oxidase (Nox2) did not develop oxidative stress, cerebrovascular dysfunction, and behavioral deficits (Park et al., 2005 (Park et al., , 2008 p47-phox -phox colocalization gp91+P47 gp91 Fig. 3 . Polyclonal antibody to RAGE and NADPH oxidase inhibitor suppressed A␤ 42 -induced colocalization of p47-phox to gp91-phox. Representative confocal images of gp91-phox and p47-phox in astrocytes (A). The images of colocalization (yellow) were obtained from merged confocal images of corresponding p47-phox (red) and gp91-phox (green) by suppressing all colors except yellow in Matlab (60X, NA 0.95 objective). Quantitative analysis of colocalization between gp91-phox and p47-phox (B). * PՅ0.05; ** PՅ0.01 compared with the control;°PՅ0.05 compared with the A␤ treatment. For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.
oligomers induce ROS production through binding to RAGE and activation of NADPH oxidase (Figs. 2 and 3) .
A␤-induced ROS generation, in turn, triggers the downstream pathway of cPLA 2 (Shelat et al., 2008) . It has been reported that the immunoreactivity of cPLA 2 (group IVA) increased in reactive astrocytes in severe AD brains (Stephenson et al., 1996 (Stephenson et al., , 1999 . In vitro, treatment of astrocytes with A␤ increased ROS production from NADPH oxidase and activated cPLA 2 (Zhu et al., 2006; Hicks et al., 2008) . Furthermore, cPLA 2 was shown to cause a decrease in mitochondrial membrane potential (⌬⌿ m ) and resulted in more ROS production (Zhu et al., 2006) . In primary rat cortical astrocytes, menadione induced ROS production mediated by NADPH oxidase (Zhu (Shelat et al., 2008) . In turn, hydrolytic products of cPLA 2 were shown to enhance NADPH oxidase activity, forming a viscous cycle (Cherny et al., 2001; Levy, 2006) . Our data showed that A␤ 42 -induced phosphorylation of cPLA 2 was totally suppressed by Ab RAGE (Fig. 4) , suggesting the involvement of RAGE in this signaling pathway.
There are several cell-specific mechanisms identified for activation of cPLA 2 . In primary astrocytes, phosphorylation of cytosolic cPLA 2 and the subsequent release of AA can be activated by G-protein-coupled receptor agonists (Yin et al., 2002; Sun et al., 2007) . In cortical neurons, protein kinase C (PKC), ERK1/2, and p38 mitogen-activated protein kinase have been involved in activation of cPLA 2 and ROS production (Sun et al., 2007) . In turn, there is a link between A␤, RAGE, and MAPKs. Several studies have indicated that A␤ induced apoptosis signalregulating kinase 1 (ASK1) dephosphorylation and p38 MAPK activation in CECs (Blanc et al., 1997; Xu et al., 2001; Yin et al., 2002; Hsu et al., 2007) . Similarly, stimulation of RAGE has also been demonstrated to mediate alterations in the phosphorylation state of MAPKs (Origlia et al., 2009) . Our data provided a link between these studies and demonstrated that binding of A␤ 42 to RAGE mediated alterations in the phosphorylation state of ERK1/2 and cPLA 2 , both in primary astrocytes as well as in CECs (Fig. 4) .
Although A␤ 42 binding to RAGE is required to induce phosphorylation of ERK1/2 and cPLA 2 in both cell types, we found the existence of two slightly different downstream pathways for CECs and astrocytes. In CECs, NADPH oxidase inhibitor gp91ds-tat and ROS scavenger tiron attenuated A␤ 42 -induced ROS production, ERK1/2 activation, and cPLA 2 phosphorylation (Fig. 5B, C, E, F) . In primary astrocytes, inhibition of NADPH oxidase and ROS production did not suppress A␤ 42 -induced ERK1/2 and cPLA 2 phosphorylation (Fig. 5A, C, D, F) . Apparently, results here are not in agreement with our previous studies showing A␤ 42 -induced ERK1/2 and cPLA 2 phosphorylation in astrocytes through NADPH oxidase (Zhu et al., 2006 (Zhu et al., , 2009 . One possible explanation is differences in use of NADPH oxidase inhibitors. In the study by Zhu et al., apocynin was used as NADPH oxidase inhibitor. Several studies indicate that apocynin can inhibit NADPH oxidase only in blood derived cells (leukocytes, microglia, etc) (Heumüller et al., 2008) , and in other cell types, this compound can act as an antioxidant (Heumüller et al., 2008) . In fact, in other cases, apocynin can even exert as an oxidant (Riganti et al., 2006) . These results suggest that effects of apocynin may different depending on experimental conditions, and thus should be interpreted with caution. In our study, we used gp91ds-tat, which is a specific NADPH oxidase inhibitor. Differences in effects of NADPH oxidase inhibition on ERK1/2 and cPLA 2 phosphorylation could also result from the preparation of astrocytes and the purity of the cell culture. Therefore, more investigations are required to unravel the mechanism(s) underlying the A␤-RAGE interaction resulting in activations of ERK1/2 and cPLA 2 in astrocytes.
In summary, this study demonstrates the important role of A␤ 42 -RAGE interaction for NADPH oxidase complex assembling, resulting in subsequent ROS generation, activation of MAPK/ERK pathway, and the phosphorylation of cPLA 2 in CECs and primary astrocytes. Our results also revealed two possibly different RAGE-dependent signaltransducing pathways in CECs and astrocytes. In CEC, it is possible to demonstrate requirement for NADPH oxidase-mediated generation of ROS to activate ERK1/2 and cPLA 2 , whereas astrocytes may activate ERK1/2 and cPLA 2 independent of NADPH oxidase. Understanding the precise molecular mechanisms underlying A␤-mediated oxidative stress should prove to provide new insights into the development of preventive and treatment strategies for AD.
